Company Analysis

AbCellera Biologics Inc. (ABCL)

Nasdaq: ABCL · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2017
Grade5.8
◀ Past 6.7● Present 5.7▶ Future 5.0
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedFeb 24, 2026Feb 27, 2025Feb 20, 2024Feb 21, 2023Feb 25, 2022Mar 30, 2021·
Revenue75,12828,83338,025485,424375,203233,15511,612
Research and development186,829167,259175,658107,87962,06229,39310,113
Sales and marketing·12,77914,18011,2706,9133,8421,263
General and administrative83,23185,490r75,179r55,48541,84811,9102,749
Total operating expenses292,231343,599275,232268,913170,79077,12415,729
Operating income-217,103-314,766-237,207216,511204,413156,031-4,117
Interest and investment income28,32938,47342,24716,0793,330293155
Share of profit of equity-method investments·1,7001,8009000··
Other income (expense), net-2,71162,2786,776-4,045-6,080r-6,811r-209
Total non-operating income (expense)39,508114,37163,17822,58814,7361,8021,906
Income before income taxes-177,595-200,395-174,029239,099219,149157,833-2,211
Income tax expense-31,183-37,538-27,63180,58065,68538,915·
Net income including non-controlling interests-146,412-162,857-146,398158,519153,464118,918-2,211
Net income-146,412-162,857-146,398158,519153,464118,918-2,211
Preferred dividends·····33,817·
Net income to common shareholders-146,412-162,857-146,398158,519153,46485,101-2,211
Earnings per share, basic-0.49-0.55-0.510.560.560.53-0.01
Earnings per share, diluted-0.49-0.55-0.510.500.480.45-0.01
Weighted average shares, basic298,707,082294,327,532289,166,486285,056,606275,763,745159,195,023151,327,560
Weighted average shares, diluted298,707,082294,327,532289,166,486314,827,255318,294,236263,129,765151,327,560
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton ABCL · research, not advice